| __timestamp | Alpine Immune Sciences, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 72471000 |
| Thursday, January 1, 2015 | 6844000 | 89204000 |
| Friday, January 1, 2016 | 8586000 | 106010000 |
| Sunday, January 1, 2017 | 6079000 | 137905000 |
| Monday, January 1, 2018 | 8362000 | 159888000 |
| Tuesday, January 1, 2019 | 9467000 | 158425000 |
| Wednesday, January 1, 2020 | 10899000 | 200677000 |
| Friday, January 1, 2021 | 14560000 | 304759000 |
| Saturday, January 1, 2022 | 17968000 | 377221000 |
| Sunday, January 1, 2023 | 22222000 | 336361000 |
Unleashing the power of data
In the competitive world of biotechnology, managing operational costs is crucial for success. This chart compares the Selling, General, and Administrative (SG&A) expenses of Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Supernus Pharmaceuticals consistently outspent Alpine Immune Sciences, with SG&A expenses peaking at approximately $377 million in 2022, a staggering 1,600% higher than Alpine's $22 million in the same year.
Alpine Immune Sciences, while maintaining a more modest budget, has shown a steady increase in expenses, growing nearly tenfold from 2014 to 2023. This trend reflects the company's strategic investments in growth and development. Meanwhile, Supernus's expenses highlight its expansive operations and market reach. Understanding these financial dynamics offers valuable insights into each company's strategic priorities and market positioning in the biotech industry.
SG&A Efficiency Analysis: Comparing Alnylam Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for BeiGene, Ltd. and Alpine Immune Sciences, Inc.
Genmab A/S and Supernus Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
Operational Costs Compared: SG&A Analysis of Blueprint Medicines Corporation and Alpine Immune Sciences, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Alpine Immune Sciences, Inc.
Alpine Immune Sciences, Inc. vs ADMA Biologics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and Apellis Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and MannKind Corporation
SG&A Efficiency Analysis: Comparing Perrigo Company plc and Supernus Pharmaceuticals, Inc.